CAPSTONE INVESTMENT ADVISORS, LLC
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1426196
NEW YORK, NY
Position in BMRN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$558,524
+$558,524 QoQ
Shares Held
9,761
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#327
of 561 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Derivatives in BMRN
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$594,300
PutShares
10,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPSTONE INVESTMENT ADVISORS, LLC holds $45,989,751 across 38 Biotechnology names. BMRN ranks #9 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
120,000 | $15,927,600 | |
| 2 | TECH |
BIO-TECHNE Corp
|
210,000 | $14,836,500 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
7,200 | $1,348,416 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
222,378 | $816,127 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,240 | $773,189 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,448 | $719,265 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
12,611 | $692,848 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,899 | $571,655 |
All Filings in BMRN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $558,524 | 9,761 | Shares | Defined | 2026-08-17 | |
| 2025-12-31 | $594,300 | 10,000 | Put | Defined | 2026-02-17 | |
| 2024-03-31 | $952,006 | 10,900 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,050,978 | 10,900 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $964,432 | 10,900 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $944,812 | 10,900 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,062,735 | 10,929 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,128,041 | 10,900 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $923,993 | 10,900 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $903,283 | 10,900 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $207,244 | 2,688 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $2,086,000 | 25,000 | Put | Sole | 2022-02-11 | |
| 2021-03-31 | $906,120 | 12,000 | Shares | Sole | 2022-02-11 | |
| 2021-03-31 | $5,104,476 | 67,600 | Put | Sole | 2022-02-11 | |
| 2020-12-31 | $6,182,145 | 70,500 | Put | Sole | 2021-06-21 | |
| 2020-12-31 | $1,423,647 | 16,235 | Shares | Sole | 2021-06-21 | |
| 2020-12-31 | $368,298 | 4,200 | Call | Sole | 2021-06-21 | |
| 2020-09-30 | $4,146,360 | 54,500 | Put | Sole | 2021-06-21 | |
| 2020-09-30 | $715,152 | 9,400 | Call | Sole | 2021-06-21 | |
| 2020-09-30 | $1,095,856 | 14,404 | Shares | Sole | 2021-06-21 | |
| 2020-06-30 | $468,692 | 3,800 | Call | Sole | 2021-06-21 | |
| 2020-06-30 | $2,854,827 | 23,146 | Shares | Sole | 2021-06-21 | |
| 2020-06-30 | $2,405,130 | 19,500 | Put | Sole | 2021-06-21 | |
| 2020-03-31 | $2,366,000 | 28,000 | Shares | Sole | 2021-06-21 | |
| No filing history on record for this holder in this stock. | ||||||